We are live on ! Find out more
DA

DCF Advisers Portfolio holdings

AUM $375M
1-Year Est. Return 72.65%
This Fund
S&P 500
This Quarter Est. Return
+9.3%
1 Year Est. Return
+72.65%
3 Year Est. Return
+156.29%
5 Year Est. Return
+218.72%
10 Year Est. Return
–
AUM
$282M
AUM Growth
+$52.2M
Cap. Flow
+$37.1M
Cap. Flow %
13.15%
Top 10 Hldgs %
53.18%
Holding
123
New
20
Increased
19
Reduced
30
Closed
30

Top Buys

Rank Stock Value
1
GDX icon
VanEck Gold Miners ETF
GDX
+$2.1M
2
ALT icon
Altimmune
ALT
+$1.99M
3
PFE icon
Pfizer
PFE
+$1.94M
4
PSFE icon
Paysafe
PSFE
+$1.38M
5
F icon
Ford
F
+$1.2M

Top Sells

Rank Stock Value
1
ORCL icon
Oracle
ORCL
+$3.33M
2
ABBV icon
AbbVie
ABBV
+$2.82M
3
T icon
AT&T
T
+$1.96M
4
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$1.83M
5
GLD icon
SPDR Gold Trust
GLD
+$1.7M

Sector Composition

Rank Sector Weight
1 Healthcare 28.83%
2 Technology 11.75%
3 Communication Services 8.8%
4 Financials 4.55%
5 Consumer Discretionary 3.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MRVL icon
51
Marvell Technology
MRVL
$168B
$1.02M 0.36%
17,500
– –
JNJ icon
52
Johnson & Johnson
JNJ
$618B
$824K 0.29%
5,000
– –
NOK icon
53
Nokia
NOK
$51B
$798K 0.28%
150,000
-19,000
-11% -$91.7K
ITW icon
54
Illinois Tool Works
ITW
$82.6B
$782K 0.28%
3,500
– –
AMRN
55
Amarin Corp
AMRN
$298M
$775K 0.27%
8,850
– –
WBD icon
56
Warner Bros
WBD
$65.9B
$767K 0.27%
+25,000
New +$867K
ADMS
57
DELISTED
Adamas Pharmaceuticals
ADMS
$739K 0.26%
140,000
-20,000
-13% -$104K
IBM icon
58
IBM
IBM
$211B
$733K 0.26%
5,230
-1,569
-23% -$215K
BDX icon
59
Becton Dickinson
BDX
$45.6B
$730K 0.26%
3,075
-4,201
-58% -$1.01M
NXPI icon
60
NXP Semiconductors
NXPI
$57.8B
$720K 0.26%
3,500
– –
AAPL icon
61
Apple
AAPL
$4.54T
$685K 0.24%
5,000
-1,000
-17% -$130K
MSFT icon
62
Microsoft
MSFT
$3.45T
$677K 0.24%
2,500
– –
VIR icon
63
Vir Biotechnology
VIR
$1.46B
$571K 0.2%
12,071
+4,879
+68% +$222K
KSS icon
64
Kohl's
KSS
$2.17B
$551K 0.2%
10,000
– –
OVID icon
65
Ovid Therapeutics
OVID
$414M
$546K 0.19%
139,701
+30,700
+28% +$121K
NKTR icon
66
Nektar Therapeutics
NKTR
$2.39B
$537K 0.19%
2,087
– –
KWEB icon
67
KraneShares CSI China Internet ETF
KWEB
$5.64B
$523K 0.19%
7,500
-10,000
-57% -$720K
BOX icon
68
Box
BOX
$4.37B
$511K 0.18%
20,000
-20,000
-50% -$466K
FDX icon
69
CALL
FedEx
FDX
$72.7B
$507K 0.18%
+1,700
New +$504K
EQ icon
70
Equillium
EQ
$139M
$457K 0.16%
+77,538
New +$489K
PARA
71
DELISTED
Paramount Global Class B
PARA
$452K 0.16%
+10,000
New +$413K
AYX
72
DELISTED
Alteryx Inc
AYX
$430K 0.15%
5,000
-1,625
-25% -$133K
GEN icon
73
Gen Digital
GEN
$16.4B
$408K 0.14%
15,000
-15,000
-50% -$374K
GMAB icon
74
Genmab
GMAB
$17.7B
$408K 0.14%
10,000
– –
FCX icon
75
Freeport-McMoran
FCX
$90B
$371K 0.13%
10,000
– –
1 2
3
4 5

Similar funds

JIC
JRM Investment Counsel Omaha, Nebraska $375M AUM 13.43% 1-Year Est. Return
CIM
CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return
AIM
Access Investment Management Atlanta, Georgia $376M AUM 17.2% 1-Year Est. Return
MWM
McMill Wealth Management Norfolk, Nebraska $376M AUM 14.46% 1-Year Est. Return
RCP
RIT Capital Partners London, United Kingdom $374M AUM 25.18% 1-Year Est. Return
HPM
Helix Partners Management New York $374M AUM 136.73% 1-Year Est. Return
CAG
Compass Advisory Group Melville, New York $374M AUM 14.59% 1-Year Est. Return
LWMNY
Landmark Wealth Management (New York) Melville, New York $373M AUM 12.01% 1-Year Est. Return

DCF Advisers's Q2 2021 Portfolio in Review

As of Q2 2021, DCF Advisers held 123 positions worth $282M, up 23% from $230M the previous quarter. Its ten largest holdings account for 53% of the portfolio.

DCF Advisers deployed $37.1M of net new capital in Q2 2021, opening 20 new positions and adding to 19 existing holdings. Its largest new stake was Altimmune: 145,750 shares worth $1.44M.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, down from 35% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Oracle, an estimated $3.33M trimmed.

  • DCF Advisers's largest Q2 2021 buy was Altimmune: 145,750 shares worth $1.44M.
  • DCF Advisers added most to VanEck Gold Miners ETF in Q2 2021, an estimated $2.1M increase.
  • DCF Advisers's biggest Q2 2021 reduction was Oracle, cutting an estimated $3.33M.
  • DCF Advisers fully exited CVS Health in Q2 2021, selling an estimated $1.62M.
  • DCF Advisers's ten largest holdings make up 53% of its $282M portfolio in Q2 2021.
  • DCF Advisers opened 20 new positions and closed 30 in Q2 2021.
  • DCF Advisers's portfolio value rose 23% quarter-over-quarter to $282M.

Based on DCF Advisers's 13F filing for Q2 2021, filed 13 Aug 2021.